Rocuronium Bromide Injection

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

45 API Suppliers, 13 USDMF, 12 CEP/COS, 3 JDMF, 3 EU WC, 5 KDMF, 10 NDC API, 30 Listed Suppliers

DEVELOPMENTS

26 Drugs in Development

26 Drugs in Development

INTERMEDIATES

15 Intermediate Suppliers

15 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

135 FDF Dossiers, 46 FDA Orange Book, 48 Europe, 6 Canada, 12 South Africa, 23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 100MG/10ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 10MG/ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 50MG/5ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Kirsch Pharma, 2 Dr. Paul Lohmann GmbH & Co. KGaA, 2 Actylis

EXCIPIENTS BY APPLICATIONS

4 Parenteral, 2 API Stability Enhancers

DIGITAL CONTENT

31 News #PharmaBuzz

31 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 Regulatory FDF Prices

4 Regulatory FDF Prices

MARKET PLACE

19 APIs, 17 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Patents

1 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 12 Others

Xls

Filters

FILTER :

filter Order Code Reset all filters

2 All

01 1Y0000527

02 1Y0001580

filter CAS Number Reset all filters

filter Reference Standard Reset all filters

Reset Filter

Price Info

Product Main Page

01

EDQM, Council of Europe

Rocuronium for peak identification

CPhI Japan

Not Confirmed

02

EDQM, Council of Europe

Rocuronium bromide

CPhI Japan

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Rocuronium Bromide Injection

Rocuronium Bromide Injection

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

45 API Suppliers

13 USDMF

12 CEP/COS

3 JDMF

3 EU WC

5 KDMF

10 NDC API

30 Listed Suppliers

DEVELOPMENTS

26 Drugs in Development

INTERMEDIATES

15 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

135 FDF Dossiers

46 FDA Orange Book

48 Europe

6 Canada

12 South Africa

23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 100MG/10ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 10MG/ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 50MG/5ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Kirsch Pharma

2 Dr. Paul Lohmann GmbH & Co. KGaA

2 Actylis

EXCIPIENTS BY APPLICATIONS

4 Parenteral

2 API Stability Enhancers

DIGITAL CONTENT

31 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 Regulatory FDF Prices

MARKET PLACE

19 APIs

17 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM

12 Others

Filters

01

EDQM, Council of Europe

01

EDQM, Council of Europe

02

EDQM, Council of Europe

02

EDQM, Council of Europe

INJECTABLE;INJECTION - 100MG/10ML (10MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 10MG/ML (10MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 50MG/5ML (10MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons